Teopek - Instructions For Use, Indications, Doses

Table of contents:

Teopek - Instructions For Use, Indications, Doses
Teopek - Instructions For Use, Indications, Doses

Video: Teopek - Instructions For Use, Indications, Doses

Video: Teopek - Instructions For Use, Indications, Doses
Video: Community Pharmacy Prescriptions II: Prednisone Dosing 2024, December
Anonim

Teopek

Instructions for use:

  1. 1. Release form and composition
  2. 2. Indications for use
  3. 3. Contraindications
  4. 4. Method of application and dosage
  5. 5. Side effects
  6. 6. Special instructions
  7. 7. Drug interactions
  8. 8. Terms and conditions of storage
Extended-release tablets Teopek
Extended-release tablets Teopek

Teopek is a bronchodilating drug, phosphodiesterase inhibitor.

Release form and composition

Teopek is available in the form of prolonged-release tablets: white, biconvex, with a risk (for 300 mg tablets), sometimes with a weak specific odor [10 pcs. in blisters, in a cardboard box 5 packs; 50 pcs. (tablets 100 mg and 200 mg) or 40 pcs. (tablets 300 mg) in plastic cans, in a carton box 1 can].

Composition for 1 tablet of prolonged action:

  • active substance: theophylline - 100 mg, 200 mg or 300 mg;
  • auxiliary components: calcium stearate, interpolymer complex of polyethylene glycol (macrogol) and polymethacrylic acid.

Indications for use

Teopek is used for the prevention and treatment of broncho-obstructive syndrome in the following diseases:

  • chronic obstructive bronchitis;
  • dermatorespiratory syndrome;
  • bronchial asthma;
  • emphysema of the lungs and other respiratory diseases.

Contraindications

  • serious heart rhythm disturbances (extrasystoles, severe tachyarrhythmias);
  • acute myocardial infarction;
  • common vascular atherosclerosis;
  • severe arterial hypotension or hypertension;
  • exacerbation of peptic ulcer of the duodenum and stomach;
  • bleeding from the gastrointestinal tract;
  • hemorrhagic stroke;
  • gastritis with high acidity;
  • hyperfunction of the thyroid gland;
  • retinal hemorrhage;
  • increased seizure activity;
  • epilepsy;
  • children's age up to three years;
  • period of pregnancy;
  • hypersensitivity to the components of the drug, as well as to other xanthine derivatives (theobromine, caffeine and pentoxifylline).

Method of administration and dosage

Teopek is intended for oral administration. The tablets are taken after meals with a little water. The tablet should be swallowed whole, without crushing, chewing or dissolving in water.

The daily dose of the drug is divided into two doses, the interval between which is 12 hours.

The selection of the optimal dose is carried out individually for each patient. When choosing a dose, the nature of the disease, the weight and age of the patient are taken into account.

The average daily dose for children 3–7 years old is 100 mg, for children 7–12 years old - 200 mg, for adults and adolescents over 14 years old - 300 mg.

The initial dose of Teopek is half the standard daily dose in two divided doses. If there are no side effects on the first day of treatment, the patient is transferred to the full daily dose.

The duration of the course of treatment varies from 2 weeks to 2 months and depends on the obtained therapeutic effect and the characteristics of the course of a particular disease.

Side effects

  • cardiovascular system: an increase in the frequency of angina attacks, arrhythmias, palpitations, cardialgia, tachycardia (including fetal tachycardia when using the drug in the third trimester of pregnancy), lowering blood pressure;
  • nervous system: headache, anxiety, tremors, insomnia, dizziness, irritability, agitation;
  • digestive system: heartburn, vomiting, gastroesophageal reflux, nausea, exacerbation of peptic ulcer disease, gastralgia; with long-term treatment - loss of appetite;
  • allergic reactions: itching, skin rash, fever;
  • other reactions: increased sweating, flushing of the face, hypoglycemia, albuminuria, tachypnea, increased urine output, hematuria, chest pain.

When the dose of theophylline is reduced, the side effects of the drug decrease.

special instructions

In smoking patients, the effectiveness of Teopec may be reduced.

The drug is not intended for the relief of acute attacks, since the bronchodilator effect of theophylline develops gradually, approximately 3–6 hours after administration.

In patients with severe liver disease, viral infections, severe diseases of the cardiovascular system and the elderly, the dose of Teopek should be reduced.

During treatment with theophylline, caffeinated drinks or foods, especially in large quantities, should be consumed with caution.

Drug interactions

Teopec is not recommended to be used simultaneously with other xanthine derivatives.

Diphenin, isoniazid, sulfinpyrazone, phenobarbital, phenytoin, carbamazepine and rifampicin reduce the effectiveness of the drug (an increase in the Teopec dose may be required).

Allopurinol, isoprenaline, oral contraceptives, influenza vaccines, macrolide antibiotics, cimetidine, enoxacin, lincomycin and beta-blockers may increase the intensity of the drug's action (a decrease in the Teopack dose may be required).

With simultaneous use with mineralocorticosteroids, glucocorticosteroids and drugs that excite the central nervous system, the risk of side effects of the listed drugs increases.

Teopec potentiates the action of diuretics and suppresses the therapeutic effects of beta-blockers and lithium carbonate.

Enterosorbents and antidiarrheals reduce the absorption of theophylline.

The drug is prescribed with caution in conjunction with anticoagulants.

Terms and conditions of storage

Store in a dark, dry place out of the reach of children, at a temperature not exceeding 25 ° C. The shelf life is 5 years.

Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!

Recommended: